Literature DB >> 15149777

Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.

N P J Vogtländer1, A Brown, R M Valentijn, G F Rimmelzwaan, A D M E Osterhaus.   

Abstract

Dialysis patients show impaired responses to several vaccines. Limited recent data are available on influenza vaccination in these patients. In the 1998-1999 influenza season, 44 dialysis patients received a standard trivalent vaccination followed by a booster two months later. The serum antibody responses in these patients were compared with those found in healthy subjects. A fourfold rise in serum hemagglutination inhibition titre was achieved in 23-58% of all patients. Protective titres were reached in 53-93% of the patients. Since protective antibody titers can be induced, it is recommended to vaccinate dialysis patients annually against influenza.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149777     DOI: 10.1016/j.vaccine.2003.11.046

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  18 in total

Review 1.  Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.

Authors:  Ken M Kunisaki; Edward N Janoff
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

2.  High-dose influenza vaccine use among patients receiving hemodialysis in the United States, 2010-2013.

Authors:  Leah J McGrath; J Bradley Layton; Whitney S Krueger; Abhijit V Kshirsagar; Anne M Butler
Journal:  Vaccine       Date:  2018-09-06       Impact factor: 3.641

3.  Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment.

Authors:  Leah J McGrath; Abhijit V Kshirsagar; Stephen R Cole; Lily Wang; David J Weber; Til Stürmer; M Alan Brookhart
Journal:  Arch Intern Med       Date:  2012-04-09

4.  Cost-effectiveness of adjuvanted versus nonadjuvanted influenza vaccine in adult hemodialysis patients.

Authors:  Bruce Y Lee; Randy M Stalter; Kristina M Bacon; Julie H Y Tai; Rachel R Bailey; Shanta M Zimmer; Michael M Wagner
Journal:  Am J Kidney Dis       Date:  2011-03-10       Impact factor: 8.860

5.  Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccine Among Patients Receiving Maintenance Hemodialysis.

Authors:  Anne M Butler; J Bradley Layton; Vikas R Dharnidharka; John M Sahrmann; Marissa J Seamans; David J Weber; Leah J McGrath
Journal:  Am J Kidney Dis       Date:  2019-08-01       Impact factor: 8.860

Review 6.  Epidemiology of acute infections among patients with chronic kidney disease.

Authors:  Lorien S Dalrymple; Alan S Go
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 8.237

Review 7.  Beyond mineral metabolism, is there an interplay between FGF23 and vitamin D in innate immunity?

Authors:  Justine Bacchetta; Isidro B Salusky; Martin Hewison
Journal:  Pediatr Nephrol       Date:  2012-11-02       Impact factor: 3.714

8.  Antibody Response to COVID-19 vaccination in Patients Receiving Dialysis.

Authors:  Shuchi Anand; Maria E Montez-Rath; Jialin Han; Pablo Garcia; LinaCel Cadden; Patti Hunsader; Russell Kerschmann; Paul Beyer; Mary Dittrich; Geoffrey A Block; Scott D Boyd; Julie Parsonnet; Glenn M Chertow
Journal:  medRxiv       Date:  2021-05-12

9.  Improving influenza and pneumococcal vaccination uptake among incident peritoneal dialysis patients: a quality improvement initiative.

Authors:  Hui Zhuan Tan; Chee Chin Phang; Sin Yan Wu; Mui Hian Sim; Michelle Meixin Law; Marjorie Wai Yin Foo; Htay Htay
Journal:  Int Urol Nephrol       Date:  2021-03-06       Impact factor: 2.370

10.  Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study.

Authors:  I-Kuan Wang; Cheng-Li Lin; Po-Chang Lin; Chih-Chia Liang; Yao-Lung Liu; Chiz-Tzung Chang; Tzung-Hai Yen; Donald E Morisky; Chiu-Ching Huang; Fung-Chang Sung
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.